BioSpace News Archive

The global artificial organ and bionics market was estimated at USD 25.4 billion in 2021 and it is expected to surpass around USD 70.1 billion by 2030, poised to grow at a CAGR of 11.94% from 2022 to 2030.

According to Report, the global bioelectric medicine market was estimated at USD 20.2 billion in 2021 and it is expected to surpass around USD 33.98 billion by 2030, poised to grow at a CAGR of 5.95 % from 2022 to 2030.

According to Vision Research Reports, the global coronary stents market was valued at USD 8.8 billion in 2021 and it is predicted to surpass around USD 12.3 billion by 2030 with a CAGR of 3.79% from 2022 to 2030.

The global formulation development outsourcing market size was estimated at around USD 31.1 billion in 2021 and it is projected to hit around USD 61.6 billion by 2030, growing at a CAGR of 7.89% from 2022 to 2030.

The global myopia and presbyopia treatment market was estimated at USD 16.5 billion in 2021 and it is expected to surpass around USD 33.9 billion by 2030, poised to grow at a CAGR of 8.33% from 2022 to 2030.

The National Human Genome Research Institute, part of the National Institutes of Health, and the National Science Teaching Association have partnered to ignite genetic and genomic curiosity in students through a new, multi-year initiative that will provide research-based instructional resources and professional learning experiences to high school educators nationwide.

Health Canada maintains a list of unauthorized health products that may pose serious health risks so that Canadians can easily identify those they may have purchased and take appropriate action.

Diabetes Research Connection, a 501 that funds research projects conducted by early-career researchers aimed at prevention, cure, and better care for those with Type 1 Diabetes, recently awarded seed funding to eight promising new T1D studies totaling a $400,000 investment, as it celebrates 10 years advancing diabetes research.

Zhittya Genesis Medicine, Inc., announced that the human test subjects in its first-in-human research study for the treatment of Parkinson’s disease, at the 30 interim examination had a 50% improvement in their motor skills.

A sensor-equipped computer program can accurately identify and count arm movements in people undergoing stroke rehabilitation, a new study shows.